Organon Australia announces local partnerships with National Youth Science Forum and Sister2sister Foundation

Save Print

November 4, 2022 12:00 pm EDT

Organon expands its commitment to advancing women’s health, gender equity and tackling climate change through partnership with local organisations.

Organon (NYSE: OGN) – a global company focused on the health and wellbeing of women, has signed partnership agreements with National Youth Science Forum (NYSF) and Sister2sister in Australia. These partnerships strengthen Organon’s purpose to support women and girls achieve their full potential by addressing gender-related disparities in wellbeing and STEM related education, and building a more sustainable future for women, families, economies and society.

“At Organon, we want to help women and girls achieve their promise by leading healthier, more empowered lives. We are working toward this purpose using multiple approaches, including innovating in women’s health, expanding access to needed medicines and other products, and advancing equity inside and outside the company,” said Nirelle Tolstoshev, Managing Director, Organon ANZ.

“Organon recently launched its first Environment, Sustainability and Governance (ESG) Report, and our partnerships with both National Youth Science Forum (supporting the Year 12 STEM Program) and Sister2sister (supporting No Limits 4Girls Program), align to our commitment to be of service to communities to support healthy lifestyles, advance the health of women, and advance equity across a number of metrics, including education and opportunity for participation.

“Our commitment goes beyond a financial contribution.  Organon’s employee volunteer policy encourages our employees to dedicate 40 regularly scheduled work hours per calendar year toward volunteer activities.

“We believe that cultivating an environment of service to the communities in which we live and work serves our employees by enriching the quality of their lives and by providing opportunities for service experiences; builds trust with our partners and enhances our employee skills, talents and experiences.”

“We look forward to the contribution Organon will bring to our programs so we can continue to provide immersive and life-changing experiences, ensuring we connect young people with the broadest possible range of STEM careers and how to get there,” said Dr Melanie Bagg, CEO, NYSF.

“Often school students have limited awareness of what careers they can enter to help others and make a tangible difference in their communities. Real-life industry insight from organisations like Organon helps our students meet real STEM professionals and explore a broad range of jobs in healthcare, pharmaceutical and the medical sector.”

“We are proud to be in partnership with Organon to deliver our No Limits 4 Girls Program (NL4G). We want young girls to feel empowered, respected, confident and equipped to make the most of opportunities that they have ahead of them. Furthermore, giving students the ability to listen to each other’s’ experiences will allow them to feel safe and connect on a deeper level. Sister2sister has had a lasting impact on many lives, and we hope NL4G has the same effect throughout these young girls’ schooling life,” commented Marnee May, CEO of Sister2sister Foundation.

“We are incredibly proud to partner with both National Youth Science Forum and Sister2sister to support the work they do in improving the health and equity for women and girls,” Tolstoshev concluded.


National Youth Science Forum (NYSF) is a not-for-profit charity that delivers youth-led immersive programs to encourage young people in their passion for STEM. Their goal is to advance Science, Technology, Engineering and Maths (STEM) education and training in the Australian community with a strong focus on equity and diversity. In particular, NYSF is a sector leader in increasing the participation of young women and those from regional and remote areas of Australia in science and technology study and careers.

SISTER2sister helps at-risk teenage girls, termed ‘Little Sisters’ by pairing them with Big Sisters in a mentoring program across 12 months. The SISTER2sister program is unique in Australia providing guidance, education, mentoring to at-risk teenage girls, by equipping them with crucial survival and life skills, the resilience to overcome challenges, and an environment fostering self-worth, the SISTER2sister mentoring program empowers them to make positive choices for a better future.

Organon will support the establishment of the new No Limit 4 Girls (NL4G) Program which will be run through high schools and complement the one-on-one mentoring relationships with a broader focus on supporting year 7 girls, as they are particularly susceptible to increased social pressure on entering high school, as well as broader cultural pressures as they enter adulthood. NL4G aim to increase girls’ resilience, emotional intelligence and stress management skills, creating a strong foundation for personal growth.


Organon (NYSE: OGN) is a global healthcare company formed through a spin-off from Merck& Co., Kenilworth, NJ, USA (NYSE: MRK) known as MSD outside of the United States and Canada, focused on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets.

Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,000 employees with headquarters located in Jersey City, New Jersey, USA.

To learn more about Organon, please visit and connect with us on LinkedIn.  

For more information:


+61 447 279 553